Creative Planning’s Aerie Pharmaceuticals AERI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-22,000
Closed -$259K 2497
2020
Q3
$259K Sell
22,000
-8,600
-28% -$105K ﹤0.01% 1519
2020
Q2
$452K Hold
30,600
﹤0.01% 1086
2020
Q1
$413K Hold
30,600
﹤0.01% 1043
2019
Q4
$740K Buy
30,600
+860
+3% +$17.8K ﹤0.01% 929
2019
Q3
$572K Sell
29,740
-600
-2% -$13.7K ﹤0.01% 992
2019
Q2
$897K Buy
30,340
+3,785
+14% +$146K ﹤0.01% 801
2019
Q1
$1.26M Buy
+26,555
New +$1.17M ﹤0.01% 633
2018
Q3
Sell
-4,200
Closed -$284K 2198
2018
Q2
$284K Hold
4,200
﹤0.01% 1408
2018
Q1
$228K Buy
4,200
+600
+17% +$33.6K ﹤0.01% 1520
2017
Q4
$215K Sell
3,600
-600
-14% -$36.4K ﹤0.01% 1560
2017
Q3
$204K Buy
4,200
+600
+17% +$32.7K ﹤0.01% 1594
2017
Q2
$189K Sell
3,600
-1
-0% -$47 ﹤0.01% 1550
2017
Q1
$163K Hold
3,601
﹤0.01% 1621
2016
Q4
$136K Buy
3,601
+501
+16% +$18.9K ﹤0.01% 1655
2016
Q3
$117K Sell
3,100
-500
-14% -$11K ﹤0.01% 1746
2016
Q2
$63K Buy
3,600
+2,200
+157% +$35.6K ﹤0.01% 1982
2016
Q1
$17K Buy
1,400
+400
+40% +$6.33K ﹤0.01% 2885
2015
Q4
$24K Sell
1,000
-300
-23% -$7K ﹤0.01% 2719
2015
Q3
$23K Buy
+1,300
New +$23.5K ﹤0.01% 2633
2015
Q2
Sell
-2,000
Closed -$63K 3285
2015
Q1
$63K Buy
+2,000
New +$58K ﹤0.01% 1857

Other funds holding AERI

Creative Planning's AERI Position: Q4 2020 in Review

Creative Planning sold out of Aerie Pharmaceuticals (AERI) in Q4 2020, closing a stake of 22,000 shares — an estimated $259K sold.

Creative Planning first reported a position in AERI in Q1 2015 and held it in 20 quarters. The position peaked at $1.26M in Q1 2019. 150 funds tracked by Wall St. Rank hold AERI as of Q4 2020.

  • Creative Planning reported no remaining Aerie Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Creative Planning sold 22,000 Aerie Pharmaceuticals shares in Q4 2020, an estimated $259K.
  • Creative Planning first reported a position in Aerie Pharmaceuticals in Q1 2015 and held it in 20 quarters.
  • Creative Planning's Aerie Pharmaceuticals position peaked at $1.26M in Q1 2019.
  • 150 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2020.

Based on Creative Planning's 13F filing for Q4 2020, filed 29 Jan 2021.